These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35950948)

  • 1. Cardiac Mechanics in Altered Hormonal States as a Surrogate for Understanding the Effects of Transgender Hormone Therapy.
    Moudgal R; Peritz DC; Turco J; Taub C
    Cardiol Rev; 2024 Jan-Feb 01; 32(1):75-82. PubMed ID: 35950948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
    Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
    Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position statement on the hormonal management of adult transgender and gender diverse individuals.
    Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
    Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
    Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
    Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease in transgender individuals.
    Murphy CN; Delles C; Davies E; Connelly PJ
    Atherosclerosis; 2023 Nov; 384():117282. PubMed ID: 37821271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review.
    Arrington-Sanders R; Connell NT; Coon D; Dowshen N; Goldman AL; Goldstein Z; Grimstad F; Javier NM; Kim E; Murphy M; Poteat T; Radix A; Schwartz A; St Amand C; Streed CG; Tangpricha V; Toribio M; Goldstein RH
    Endocr Pract; 2023 Apr; 29(4):272-278. PubMed ID: 36539066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
    Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
    Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.
    Aranda G; Halperin I; Gomez-Gil E; Hanzu FA; Seguí N; Guillamon A; Mora M
    Front Endocrinol (Lausanne); 2021; 12():718200. PubMed ID: 34659112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
    Cirrincione LR; Narla RR
    J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.